McCarthy Asset Management’s Turn Therapeutics TTRX Stock Holding History

McCarthy Asset Management’s Portfolio TTRX Stock Details TTRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$216K	Hold	15,018	–	–	0.1%	27
2026 Q2	$110K	Buy	+15,018	New	+$69.8K	0.05%	29

Other funds holding TTRX

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Pflug Koory Omaha, Nebraska $243M AUM 30.88% 1-Year Est. Return

McCarthy Asset Management's TTRX Position: Q3 2026 in Review

McCarthy Asset Management held its Turn Therapeutics (TTRX) position steady in Q3 2026 at 15,018 shares worth $216K. The position accounts for 0.1% of the portfolio, ranked #27.

McCarthy Asset Management first reported a position in TTRX in Q2 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

McCarthy Asset Management held 15,018 shares of Turn Therapeutics worth $216K as of Q3 2026.
McCarthy Asset Management left its Turn Therapeutics share count unchanged in Q3 2026.
Turn Therapeutics made up 0.1% of McCarthy Asset Management's portfolio in Q3 2026, its #27 holding.
McCarthy Asset Management first reported a position in Turn Therapeutics in Q2 2026 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on McCarthy Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.